报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 41.01% | 0.69% | -5.11% | 95/158 | 22.23% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 43.22% | 6.59% | -0.79% | 91/158 | 32.75% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 43.56% | 13.56% | 9.35% | 89/158 | 51.26% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 39.84% | 11.89% | -2.2% | 104/158 | 51.17% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 40.73% | 16.9% | 0.46% | 103/158 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 40.55% | 16.17% | 5.7% | 101/158 | 38.03% | 迈威生物 | 99.8% | 行业排名> |
2023-03-31 | 38.36% | 2% | 7.74% | 104/158 | 52.88% | 迈威生物 | 99.46% | 行业排名> |
2022-12-31 | 35.6% | -11.2% | 2.18% | 111/158 | 53.39% | 迈威生物 | 99.75% | 行业排名> |
2022-09-30 | 34.84% | 2% | -0.18% | 106/158 | 6.36% | 迈威生物 | 99.67% | 行业排名> |
2022-06-30 | 34.9% | -18.3% | -12.95% | 109/158 | 21.22% | 迈威生物 | 99.44% | 行业排名> |
2021-12-31 | 40.09% | -11.76% | -6.15% | 103/158 | 54.96% | 迈威生物 | 98.57% | 行业排名> |
2021-06-30 | 42.72% | 2% | -5.98% | 92/158 | 47.38% | 首药控股 | 99.93% | 行业排名> |
2020-12-31 | 45.44% | 11.97% | 11.97% | 93/158 | -145.98% | 艾力斯 | 99.41% | 行业排名> |
2019-12-31 | 40.58% | 72.54% | 72.54% | 99/158 | -1213.5% | 艾力斯 | 98.7% | 行业排名> |
2018-12-31 | 23.52% | 2% | 2% | 125/158 | -207.91% | 艾力斯 | 99.4% | 行业排名> |